Literature DB >> 7302871

Amelioration of teratogenesis. I. Modification of hydroxyurea-induced teratogenesis by the antioxidant propyl gallate.

J M DeSesso.   

Abstract

Hydroxyurea (HU) is a potent teratogen which caused 100% embryotoxic effects in New Zealand white rabbits when injected sc on gestational day 12. These included a high percentage of resorptions and severe craniofacial, trunk and limb deformities of all survivors. Co-treatment of pregnant animals with the phenolic antioxidant propyl gallate (PG) resulted in amelioration of the embryotoxicity. Various amounts of PG (362-906 mg/kg) and HU (600-750 mg/kg) were eigher injected simultaneously or mixed together for periods of time up to 45 min. The extent of amelioration was dependent upon the amount of PG, although the highest dose of PG caused maternal toxicity. Simultaneous injections of HU and PG were not as efficacious as mixture of the two chemicals prior to injection. The length of time which the HU and PG mixture was allowed to stand prior to injection had no effect on the extent of amelioration. The protective action of PG resulted in significant linear reductions in both resorptions and specific malformations with increasing doses of PG. Histologic analysis of HU and HU-PG embryos disclosed that HU produced rapid cell death in the mesenchymal compartment of the embryo, particularly in the limb-buds, beginning at 2 h after treatment. Cell debris increased in amount until 8 h and remained extensive at 16 h. In contrast, HU-PG delayed the onset for cell death until 8 h. Nevertheless, at 16 h, the amount of cell debris in the limb-buds was appreciable. Thin layer chromatography (TLC) of HU-PG solution revealed no breakdown products or intermediate compounds suggesting that HU and PG do not react chemically. The presence of HU within both HU and HU-PG treated embryos was confirmed by TLC of embryonic sonicants. In contrast, TLC of embryonic extracts revealed PG only in HU-PG embryos. Light microscopy of other embryos from those same litters demonstrated extensive cell debris in the HU embryos but not in HU-PG embryos. It is suggested that the delay in onset of HU cytotoxicity is caused by the antioxidant properties of PG acting within the embryos, and that this may account for the amelioration of HU teratogenesis by PG.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7302871     DOI: 10.1002/tera.1420240104

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  7 in total

1.  Teratogen-induced oxidative stress targets glyceraldehyde-3-phosphate dehydrogenase in the organogenesis stage mouse embryo.

Authors:  Ava E Schlisser; Jin Yan; Barbara F Hales
Journal:  Toxicol Sci       Date:  2010-10-01       Impact factor: 4.849

2.  Cytotoxicity of propyl gallate and related compounds in rat hepatocytes.

Authors:  Y Nakagawa; S Tayama
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

3.  Interagency regulatory liaison group workshop on reproductive toxicity risk assessment.

Authors:  C A Kimmel; G L Kimmel; V Frankos
Journal:  Environ Health Perspect       Date:  1986-04       Impact factor: 9.031

4.  The teratogenicity and the action mechanism of gallic acid relating with brain and cervical muscles.

Authors:  Chiu Lan Hsieh; Chien-Hong Lin; Kuan Chou Chen; Chiung-Chi Peng; Robert Y Peng
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

Review 5.  The Cell Killing Mechanisms of Hydroxyurea.

Authors:  Amanpreet Singh; Yong-Jie Xu
Journal:  Genes (Basel)       Date:  2016-11-17       Impact factor: 4.096

6.  Shoutai pills improve the quality of oocytes exposed to the chemotherapeutic drug Hydroxyurea.

Authors:  Yuwei Zhang; Ruizhi Tan; Li Wang; Xiaoyan Shi; Yu Li; Xia Zhong; Xiaoxia He; Bo Xiong
Journal:  Aging (Albany NY)       Date:  2020-05-10       Impact factor: 5.682

Review 7.  Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?

Authors:  Sunčica Kapor; Vladan Čokić; Juan F Santibanez
Journal:  Oxid Med Cell Longev       Date:  2021-10-18       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.